Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Farrell

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Diagnostic Microbiology and Infectious Disease|July 13, 2015
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013)Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficileDavid J Farrell, Shannon D Putnam, Douglas J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|January 31, 2015
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance programRobert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Microbiology (Reading, England)|April 1, 2008
Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002Suzanne J C Verhaegh, André Streefland, Joy K Dewnarain, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitalsHelio S Sader, David J Farrell, Robert K Flamm, et al.
Journal of Chemotherapy (Florence, Italy)|November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countriesRobert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 1, 2015
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for CeftobiproleRodrigo E Mendes, Lalitagauri M Deshpande, Andrew J Costello, et al.
Diagnostic Microbiology and Infectious Disease|June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2015
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancinRonald N Jones, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2015
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanismsRobert K Flamm, Paul R Rhomberg, Katie M Simpson, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Diagnostic Microbiology and Infectious Disease|July 13, 2015
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013)Helio S Sader, Mariana Castanheira, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2010
In vitro activity and single-step mutational analysis of rifamycin SV tested against enteropathogens associated with traveler's diarrhea and Clostridium difficileDavid J Farrell, Shannon D Putnam, Douglas J Biedenbach, et al.
Diagnostic Microbiology and Infectious Disease|January 31, 2015
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance programRobert K Flamm, Rodrigo E Mendes, Patricia A Hogan, et al.
Microbiology (Reading, England)|April 1, 2008
Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002Suzanne J C Verhaegh, André Streefland, Joy K Dewnarain, et al.
Diagnostic Microbiology and Infectious Disease|March 14, 2016
Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitalsHelio S Sader, David J Farrell, Robert K Flamm, et al.
Journal of Chemotherapy (Florence, Italy)|November 24, 2012
ZAAPS Program results for 2010: an activity and spectrum analysis of linezolid using clinical isolates from 75 medical centres in 24 countriesRobert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 1, 2015
Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for CeftobiproleRodrigo E Mendes, Lalitagauri M Deshpande, Andrew J Costello, et al.
Diagnostic Microbiology and Infectious Disease|June 19, 2012
LEADER surveillance program results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates from the United States (61 medical centers)Robert K Flamm, David J Farrell, Rodrigo E Mendes, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2015
Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancinRonald N Jones, David J Farrell, Robert K Flamm, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2015
In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanismsRobert K Flamm, Paul R Rhomberg, Katie M Simpson, et al.
Pageof 18